Search hospitals > Missouri > Springfield
CoxHealth South Hospital
Claim this profileSpringfield, Missouri 65807
Global Leader in Breast Cancer
Global Leader in Ovarian Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
391 reported clinical trials
9 medical researchers
Summary
CoxHealth South Hospital is a medical facility located in Springfield, Missouri. This center is recognized for care of Breast Cancer, Ovarian Cancer, Lung Cancer, Cancer, Breast cancer and other specialties. CoxHealth South Hospital is involved with conducting 391 clinical trials across 534 conditions. There are 9 research doctors associated with this hospital, such as Jay W Carlson, Tania Papsdorf, MD, Srikant Nannapaneni, and Benjamin Lisle, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Ovarian Cancer
Global LeaderBRCA1 positive
Stage IV
Stage III
Top PIs
Jay W CarlsonMercy Hospital Saint Louis6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
219 reported clinical trials
295 drugs studied
Tania Papsdorf, MDCoxHealth3 years of reported clinical research
Studies Amyotrophic Lateral Sclerosis
Studies Pick's Disease
2 reported clinical trials
2 drugs studied
Srikant NannapaneniCox South Hospital5 years of reported clinical research
Studies Cancer
Studies Melanoma
2 reported clinical trials
3 drugs studied
Benjamin Lisle, MDCox Medical Center South5 years of reported clinical research
Studies Stroke
Studies Atrial Fibrillation
2 reported clinical trials
3 drugs studied
Clinical Trials running at CoxHealth South Hospital
Lung Cancer
Breast Cancer
Bladder Cancer
Breast cancer
Prostate Cancer
Cancer
Ovarian Cancer
Colorectal Cancer
Esophageal cancer
Kidney Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at CoxHealth South Hospital?
CoxHealth South Hospital is a medical facility located in Springfield, Missouri. This center is recognized for care of Breast Cancer, Ovarian Cancer, Lung Cancer, Cancer, Breast cancer and other specialties. CoxHealth South Hospital is involved with conducting 391 clinical trials across 534 conditions. There are 9 research doctors associated with this hospital, such as Jay W Carlson, Tania Papsdorf, MD, Srikant Nannapaneni, and Benjamin Lisle, MD.
Where is CoxHealth South Hospital located?
CoxHealth South Hospital is located at 3801 S. National Ave., Springfield, MO 65807.
Who should I call to ask about financial aid or insurance network?
For financial assistance at CoxHealth South Hospital, please call a financial counselor at 417-269-3117. For insurance-related inquiries, insured individuals should contact their provider, while uninsured individuals should refer to Schedule 6. For general inquiries, contact CoxHealth at 417-269-3000.
What insurance does CoxHealth South Hospital accept?
CoxHealth South Hospital accepts a wide range of insurance plans, such as Humana Commercial Products, Humana Medicare Advantage, Healthy Blue Missouri (Managed Medicaid), MedRisk, LLC, UnitedHealthcare, Aetna, Anthem, Blue Cross Blue Shield, Cigna, Mid America Health, and One Health Plan. Always verify with the hospital or your insurance provider to confirm coverage.
What awards or recognition has CoxHealth South Hospital received?
CoxHealth South Hospital, located in Springfield, Missouri, is a Certified Treatment Center of Excellence for its ALS Clinic, as recognized by The ALS Association. Furthermore, CoxHealth's Springfield hospitals, including Cox Medical Center South, have achieved Magnet recognition, signifying excellence in nursing and high-quality patient care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.